These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2173580

  • 1. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP.
    Lofton CE, Newman WH, Currie MG.
    Biochem Biophys Res Commun; 1990 Oct 30; 172(2):793-9. PubMed ID: 2173580
    [Abstract] [Full Text] [Related]

  • 2. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells.
    Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW.
    Circ Res; 1995 Feb 30; 76(2):199-208. PubMed ID: 7834830
    [Abstract] [Full Text] [Related]

  • 3. Modulation of barrier function of bovine aortic and pulmonary artery endothelial cells: dissociation from cytosolic calcium content.
    Buchan KW, Martin W.
    Br J Pharmacol; 1992 Dec 30; 107(4):932-8. PubMed ID: 1334754
    [Abstract] [Full Text] [Related]

  • 4. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.
    Kato J, Lanier-Smith KL, Currie MG.
    J Biol Chem; 1991 Aug 05; 266(22):14681-5. PubMed ID: 1650366
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
    Surapisitchat J, Jeon KI, Yan C, Beavo JA.
    Circ Res; 2007 Oct 12; 101(8):811-8. PubMed ID: 17704206
    [Abstract] [Full Text] [Related]

  • 6. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers.
    Baron DA, Lofton CE, Newman WH, Currie MG.
    Proc Natl Acad Sci U S A; 1989 May 12; 86(9):3394-8. PubMed ID: 2524068
    [Abstract] [Full Text] [Related]

  • 7. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers.
    Westendorp RG, Draijer R, Meinders AE, van Hinsbergh VW.
    J Vasc Res; 1994 May 12; 31(1):42-51. PubMed ID: 7903872
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells.
    Saijonmaa O, Fyhrquist F.
    Cardiovasc Res; 1998 Oct 12; 40(1):206-10. PubMed ID: 9876333
    [Abstract] [Full Text] [Related]

  • 9. Atriopeptin-induced increases in endothelial cell permeability are associated with elevated cGMP levels.
    Yonemaru M, Ishii K, Murad F, Raffin TA.
    Am J Physiol; 1992 Sep 12; 263(3 Pt 1):L363-9. PubMed ID: 1329530
    [Abstract] [Full Text] [Related]

  • 10. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells.
    Emori T, Hirata Y, Imai T, Eguchi S, Kanno K, Marumo F.
    Endocrinology; 1993 Dec 12; 133(6):2474-80. PubMed ID: 8243267
    [Abstract] [Full Text] [Related]

  • 11. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.
    Nazario B, Hu RM, Pedram A, Prins B, Levin ER.
    J Clin Invest; 1995 Mar 12; 95(3):1151-7. PubMed ID: 7883964
    [Abstract] [Full Text] [Related]

  • 12. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells.
    Klinger JR, Warburton R, Carino GP, Murray J, Murphy C, Napier M, Harrington EO.
    Exp Cell Res; 2006 Feb 15; 312(4):401-10. PubMed ID: 16360149
    [Abstract] [Full Text] [Related]

  • 13. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells.
    Kiemer AK, Bildner N, Weber NC, Vollmar AM.
    Endocrinology; 2003 Mar 15; 144(3):802-12. PubMed ID: 12586756
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability.
    Hempel A, Noll T, Bach C, Piper HM, Willenbrock R, Höhnel K, Haller H, Luft FC.
    Am J Physiol; 1998 Nov 15; 275(5):H1818-25. PubMed ID: 9815090
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of endothelial cell clearance of atrial natriuretic peptide by cyclic GMP treatment.
    Kato J, Oehlenschlager WF, Newman WH, Currie MG.
    Biochem Biophys Res Commun; 1992 Jan 15; 182(1):420-4. PubMed ID: 1310019
    [Abstract] [Full Text] [Related]

  • 16. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.
    Kishi Y, Ashikaga T, Watanabe R, Numano F.
    J Cardiovasc Pharmacol; 1994 Sep 15; 24(3):351-7. PubMed ID: 7528289
    [Abstract] [Full Text] [Related]

  • 17. Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release.
    Verspohl EJ, Ammon HP.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar 15; 339(3):348-53. PubMed ID: 2542810
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle.
    Hamad AM, Johnson SR, Knox AJ.
    Am J Physiol; 1999 Nov 15; 277(5):L910-8. PubMed ID: 10564175
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro.
    Akamatsu N, Inenaga K, Yamashita H.
    J Neuroendocrinol; 1993 Oct 15; 5(5):517-22. PubMed ID: 8680419
    [Abstract] [Full Text] [Related]

  • 20. Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells.
    Hölschermann H, Noll T, Hempel A, Piper HM.
    Am J Physiol; 1997 Jan 15; 272(1 Pt 2):H91-8. PubMed ID: 9038926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.